We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
Cap. Flow
-$1.46B
Cap. Flow %
-2.85%
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163

Sector Composition

Rank Sector Weight
1 Technology 21.75%
2 Healthcare 16.63%
3 Financials 14.77%
4 Consumer Discretionary 11.39%
5 Communication Services 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
876
Dyne Therapeutics
DYN
$4.71B
$2.1M ﹤0.01%
+100,000
New +$1.88M
RCUS icon
877
Arcus Biosciences
RCUS
$3.47B
$2.06M ﹤0.01%
75,000
-175,000
-70% -$5M
CGEM icon
878
Cullinan Oncology
CGEM
$999M
$2.01M ﹤0.01%
78,000
-263,731
-77% -$8.11M
PMVP icon
879
PMV Pharmaceuticals
PMVP
$59.7M
$1.81M ﹤0.01%
53,000
-25,000
-32% -$835K
PNTM.WS
880
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$1.78M ﹤0.01%
1,800,000
OII icon
881
Oceaneering
OII
$4.85B
$1.71M ﹤0.01%
110,000
-20,000
-15% -$279K
CAS
882
DELISTED
Cascade Acquisition Corp.
CAS
$1.71M ﹤0.01%
173,050
REZI icon
883
Resideo Technologies
REZI
$5.49B
$1.61M ﹤0.01%
53,652
BOAC.WS
884
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$1.58M ﹤0.01%
1,168,750
-1,096,875
-48% -$1.61M
PRGO icon
885
Perrigo
PRGO
$1.48B
$1.51M ﹤0.01%
+32,917
New +$1.46M
ITOS
886
DELISTED
iTeos Therapeutics
ITOS
$1.46M ﹤0.01%
56,893
-1,200,000
-95% -$28.6M
LUMN icon
887
Lumen
LUMN
$6.65B
$1.41M ﹤0.01%
+103,379
New +$1.43M
IMPX.WS
888
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$1.36M ﹤0.01%
1,419,459
-255,541
-15% -$228K
SLGCW
889
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$1.35M ﹤0.01%
+250,000
New +$1.29M
APSG.WS
890
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$1.29M ﹤0.01%
1,085,200
-866,666
-44% -$973K
EQRXW
891
DELISTED
EQRx, Inc. Warrant
EQRXW
$1.29M ﹤0.01%
+500,000
New +$1.33M
STR
892
DELISTED
Sitio Royalties
STR
$1.27M ﹤0.01%
62,500
+25,000
+67% +$480K
PDAC
893
DELISTED
Peridot Acquisition Corp.
PDAC
$1.22M ﹤0.01%
100,000
-105,755
-51% -$1.14M
MIT.WS
894
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$1.22M ﹤0.01%
1,350,000
HZAC.WS
895
DELISTED
Horizon Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary sh
HZAC.WS
$1.19M ﹤0.01%
666,666
BWEN icon
896
Broadwind
BWEN
$95.5M
$1.13M ﹤0.01%
+250,000
New +$1.23M
ARNC
897
DELISTED
Arconic Corporation
ARNC
$1.13M ﹤0.01%
31,789
EQT icon
898
EQT Corp
EQT
$33.5B
$1.11M ﹤0.01%
50,000
METC icon
899
Ramaco Resources Class A
METC
$581M
$1.09M ﹤0.01%
206,718
IS
900
DELISTED
ironSource Ltd.
IS
$1.05M ﹤0.01%
+100,000
New +$1.07M

Similar funds

Adage Capital Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
  • Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
  • Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
  • Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
  • Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
  • Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
  • Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.

Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.